SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) announced it will initiate FDA-enabling toxicology and pharmacology studies for its diabetes and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE